Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Covington
Express Scripts
QuintilesIMS
Chinese Patent Office
McKinsey
Cerilliant
Harvard Business School
AstraZeneca
Dow

Generated: August 16, 2017

DrugPatentWatch Database Preview

Halobetasol propionate - Generic Drug Details

« Back to Dashboard

What are the generic sources for halobetasol propionate and what is the scope of halobetasol propionate patent protection?

Halobetasol propionate
is the generic ingredient in two branded drugs marketed by Fougera Pharms, G And W Labs Inc, G And W Labs, Perrigo Israel, Taro, Sun Pharm Inds Ltd, Ranbaxy, and Sun Pharm Inds, and is included in twelve NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Halobetasol propionate has fourteen patent family members in fourteen countries.

There are nine drug master file entries for halobetasol propionate. Nine suppliers are listed for this compound.

Summary for Generic Name: halobetasol propionate

Tradenames:2
Patents:1
Applicants:8
NDAs:12
Drug Master File Entries: see list9
Suppliers / Packagers: see list9
Bulk Api Vendors: see list38
Clinical Trials: see list336
Patent Applications: see list3,290
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Drug Prices:see low prices
DailyMed Link:halobetasol propionate at DailyMed

Pharmacology for Ingredient: halobetasol propionate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Taro
HALOBETASOL PROPIONATE
halobetasol propionate
OINTMENT;TOPICAL076994-001Dec 16, 2004ABRXNoNo► Subscribe► Subscribe► Subscribe
Fougera Pharms
HALOBETASOL PROPIONATE
halobetasol propionate
OINTMENT;TOPICAL076903-001Dec 16, 2004DISCNNoNo► Subscribe► Subscribe► Subscribe
Perrigo Israel
HALOBETASOL PROPIONATE
halobetasol propionate
CREAM;TOPICAL077123-001Dec 16, 2004ABRXNoNo► Subscribe► Subscribe► Subscribe
G And W Labs
HALOBETASOL PROPIONATE
halobetasol propionate
OINTMENT;TOPICAL077721-001Sep 7, 2006ABRXNoYes► Subscribe► Subscribe► Subscribe
G And W Labs
HALOBETASOL PROPIONATE
halobetasol propionate
CREAM;TOPICAL078162-001Apr 24, 2007ABRXNoYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: halobetasol propionate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sun Pharm Inds Ltd
ULTRAVATE
halobetasol propionate
CREAM;TOPICAL019967-001Dec 27, 1990► Subscribe► Subscribe
Ranbaxy
ULTRAVATE
halobetasol propionate
OINTMENT;TOPICAL019968-001Dec 17, 1990► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: halobetasol propionate

Country Document Number Estimated Expiration
Singapore11201502931Y► Subscribe
Australia2013331271► Subscribe
Eurasian Patent Organization201590730► Subscribe
China104884043► Subscribe
Hong Kong1214154► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Chinese Patent Office
Citi
Cipla
Teva
McKesson
Novartis
Merck
Harvard Business School
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot